Loading…

Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency

A series of 7-amino-4-chloro-3-(3-isothioureidopropoxy)isocoumarin (NH2-CiTPrOIC) derivatives with various substituents at the 7- and 3-positions have been synthesized as inhibitors of several blood coagulation enzymes. Isocoumarins substituted with basic groups such as guanidino or isothioureidoalk...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1994-04, Vol.37 (9), p.1298-1306
Main Authors: Kam, Chih-Min, Kerrigan, John E, Plaskon, R. Richard, Duffy, Edward J, Lollar, Pete, Suddath, F. L, Powers, James C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a383t-4f28e36335f529ef3392a1b34699d99923c5538ee647745cb183a70ea04652603
cites
container_end_page 1306
container_issue 9
container_start_page 1298
container_title Journal of medicinal chemistry
container_volume 37
creator Kam, Chih-Min
Kerrigan, John E
Plaskon, R. Richard
Duffy, Edward J
Lollar, Pete
Suddath, F. L
Powers, James C
description A series of 7-amino-4-chloro-3-(3-isothioureidopropoxy)isocoumarin (NH2-CiTPrOIC) derivatives with various substituents at the 7- and 3-positions have been synthesized as inhibitors of several blood coagulation enzymes. Isocoumarins substituted with basic groups such as guanidino or isothioureidoalkoxy groups were previously shown to be potent irreversible inhibitors of blood coagulation enzymes [Kam et al. Biochemistry 1988, 27, 2547-2557]. Substituted isocoumarins with an isothioureidoethoxy group at the 3-position and a large hydrophobic group at the 7-position are better inhibitors for thrombin, factor VIIa, factor Xa, factor XIa, factor IIa, and factor IXa than NH2-CiTPrOIC (4). PhNHCONH-CiTEtOIC (14), (S)-Ph(CH3)CHNHCONH-CiTEtOIC (25), and (R)-Ph(CH3)CHNHCONH-CiTEtOIC (26) inhibit thrombin quite potently and have kobs/[I] values of (1-4) x 10(4) M-1 s-1. Modeled structures of several isocoumarins noncovalently complexed with human alpha-thrombin suggest that H-bonding between the 7-substituent and the Lys-60F NH3+ relates to the inhibitory potency. Thrombin inhibited by 14, 25, or 26 is quite stable, and only 4-16% of enzymatic activity is regained after incubation for 20 days in 0.1 M Hepes, pH 7.5 buffer. However, 100, 67, and 65% of enzyme activity, respectively, is regained with the addition of 0.38 M hydroxylamine. With normal citrated pig or human plasma, these isocoumarin derivatives prolong the prothrombin time ca. 1.3-3.1-fold and also prolong the activated partial thromboplastin time more than 3-7-fold at 32 microM. Thus, these compounds are effective anticoagulants in vitro and may be useful in vivo.
doi_str_mv 10.1021/jm00035a009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76465219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76465219</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-4f28e36335f529ef3392a1b34699d99923c5538ee647745cb183a70ea04652603</originalsourceid><addsrcrecordid>eNptkc1uEzEUhS0EKiGwYo3kBeJHyMVjz9gzyzQUiFREUAoLNpbj8RCnM77F9kjNK_JUOEoUumDlxfl87rn3IPS8oOcFZcX77UAp5ZWmtHmAJkXFKClrWj5EE0oZI0ww_hg9iXG7xwrGz9BZXUghqZygP1-s2Wjv4kAudLQtXkQwMA46OI8XfuPWLkGIuIOAL3qAFs9B_xp7nRx4vLIZs3gZINn8O57jy66zJmHocNpYLMlqXMfk0mh9wtlRktngPJCSmE0PAQgnb1yEtHEwButa0P0N3O3eun8pIoZ7SXZY-xbPfHLmkCP7LvN0b3ZP0aNO99E-O75T9P3j5fX8M7n6-mkxn10RzWueSNmx2nLBedVVrLEd5w3TxZqXomnapmkYN1XFa2tFKWVZmXVRcy2p1bQUFROUT9Grg-9tgN-jjUkNLhrb5ywWxqik2INFk8F3B9AEiDHYTt0Gl3faqYKqfXPqXnOZfnG0HdeDbU_ssaqsvzzqOhrdd0F74-IJK6kQNG81ReSAuZjs3UnW4UYJyWWlrpcrtax-_PxQN9_UfuzrA69NVNvcgs-3-2_Av5nhvng</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76465219</pqid></control><display><type>article</type><title>Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency</title><source>ACS CRKN Legacy Archives</source><creator>Kam, Chih-Min ; Kerrigan, John E ; Plaskon, R. Richard ; Duffy, Edward J ; Lollar, Pete ; Suddath, F. L ; Powers, James C</creator><creatorcontrib>Kam, Chih-Min ; Kerrigan, John E ; Plaskon, R. Richard ; Duffy, Edward J ; Lollar, Pete ; Suddath, F. L ; Powers, James C</creatorcontrib><description>A series of 7-amino-4-chloro-3-(3-isothioureidopropoxy)isocoumarin (NH2-CiTPrOIC) derivatives with various substituents at the 7- and 3-positions have been synthesized as inhibitors of several blood coagulation enzymes. Isocoumarins substituted with basic groups such as guanidino or isothioureidoalkoxy groups were previously shown to be potent irreversible inhibitors of blood coagulation enzymes [Kam et al. Biochemistry 1988, 27, 2547-2557]. Substituted isocoumarins with an isothioureidoethoxy group at the 3-position and a large hydrophobic group at the 7-position are better inhibitors for thrombin, factor VIIa, factor Xa, factor XIa, factor IIa, and factor IXa than NH2-CiTPrOIC (4). PhNHCONH-CiTEtOIC (14), (S)-Ph(CH3)CHNHCONH-CiTEtOIC (25), and (R)-Ph(CH3)CHNHCONH-CiTEtOIC (26) inhibit thrombin quite potently and have kobs/[I] values of (1-4) x 10(4) M-1 s-1. Modeled structures of several isocoumarins noncovalently complexed with human alpha-thrombin suggest that H-bonding between the 7-substituent and the Lys-60F NH3+ relates to the inhibitory potency. Thrombin inhibited by 14, 25, or 26 is quite stable, and only 4-16% of enzymatic activity is regained after incubation for 20 days in 0.1 M Hepes, pH 7.5 buffer. However, 100, 67, and 65% of enzyme activity, respectively, is regained with the addition of 0.38 M hydroxylamine. With normal citrated pig or human plasma, these isocoumarin derivatives prolong the prothrombin time ca. 1.3-3.1-fold and also prolong the activated partial thromboplastin time more than 3-7-fold at 32 microM. Thus, these compounds are effective anticoagulants in vitro and may be useful in vivo.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00035a009</identifier><identifier>PMID: 8176707</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Amino Acid Sequence ; Animals ; Anticoagulants - chemistry ; Anticoagulants - pharmacology ; Binding Sites ; Blood Coagulation - drug effects ; Cattle ; Chemistry ; Coumarins - chemistry ; Coumarins - metabolism ; Coumarins - pharmacology ; Exact sciences and technology ; Factor IXa - antagonists &amp; inhibitors ; Factor VIIIa - pharmacology ; Heterocyclic compounds ; Heterocyclic compounds with o, s, se, te hetero atom and condensed derivatives ; Humans ; Hydrolysis ; Isocoumarins ; Liposomes - metabolism ; Models, Molecular ; Molecular Sequence Data ; Molecular Structure ; Organic chemistry ; Preparations and properties ; Serine Proteinase Inhibitors - chemistry ; Serine Proteinase Inhibitors - pharmacology ; Swine ; Thrombin - antagonists &amp; inhibitors ; Thrombin - chemistry</subject><ispartof>Journal of medicinal chemistry, 1994-04, Vol.37 (9), p.1298-1306</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a383t-4f28e36335f529ef3392a1b34699d99923c5538ee647745cb183a70ea04652603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00035a009$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00035a009$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27063,27923,27924,56765,56815</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4066063$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8176707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kam, Chih-Min</creatorcontrib><creatorcontrib>Kerrigan, John E</creatorcontrib><creatorcontrib>Plaskon, R. Richard</creatorcontrib><creatorcontrib>Duffy, Edward J</creatorcontrib><creatorcontrib>Lollar, Pete</creatorcontrib><creatorcontrib>Suddath, F. L</creatorcontrib><creatorcontrib>Powers, James C</creatorcontrib><title>Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of 7-amino-4-chloro-3-(3-isothioureidopropoxy)isocoumarin (NH2-CiTPrOIC) derivatives with various substituents at the 7- and 3-positions have been synthesized as inhibitors of several blood coagulation enzymes. Isocoumarins substituted with basic groups such as guanidino or isothioureidoalkoxy groups were previously shown to be potent irreversible inhibitors of blood coagulation enzymes [Kam et al. Biochemistry 1988, 27, 2547-2557]. Substituted isocoumarins with an isothioureidoethoxy group at the 3-position and a large hydrophobic group at the 7-position are better inhibitors for thrombin, factor VIIa, factor Xa, factor XIa, factor IIa, and factor IXa than NH2-CiTPrOIC (4). PhNHCONH-CiTEtOIC (14), (S)-Ph(CH3)CHNHCONH-CiTEtOIC (25), and (R)-Ph(CH3)CHNHCONH-CiTEtOIC (26) inhibit thrombin quite potently and have kobs/[I] values of (1-4) x 10(4) M-1 s-1. Modeled structures of several isocoumarins noncovalently complexed with human alpha-thrombin suggest that H-bonding between the 7-substituent and the Lys-60F NH3+ relates to the inhibitory potency. Thrombin inhibited by 14, 25, or 26 is quite stable, and only 4-16% of enzymatic activity is regained after incubation for 20 days in 0.1 M Hepes, pH 7.5 buffer. However, 100, 67, and 65% of enzyme activity, respectively, is regained with the addition of 0.38 M hydroxylamine. With normal citrated pig or human plasma, these isocoumarin derivatives prolong the prothrombin time ca. 1.3-3.1-fold and also prolong the activated partial thromboplastin time more than 3-7-fold at 32 microM. Thus, these compounds are effective anticoagulants in vitro and may be useful in vivo.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Anticoagulants - chemistry</subject><subject>Anticoagulants - pharmacology</subject><subject>Binding Sites</subject><subject>Blood Coagulation - drug effects</subject><subject>Cattle</subject><subject>Chemistry</subject><subject>Coumarins - chemistry</subject><subject>Coumarins - metabolism</subject><subject>Coumarins - pharmacology</subject><subject>Exact sciences and technology</subject><subject>Factor IXa - antagonists &amp; inhibitors</subject><subject>Factor VIIIa - pharmacology</subject><subject>Heterocyclic compounds</subject><subject>Heterocyclic compounds with o, s, se, te hetero atom and condensed derivatives</subject><subject>Humans</subject><subject>Hydrolysis</subject><subject>Isocoumarins</subject><subject>Liposomes - metabolism</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Molecular Structure</subject><subject>Organic chemistry</subject><subject>Preparations and properties</subject><subject>Serine Proteinase Inhibitors - chemistry</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Swine</subject><subject>Thrombin - antagonists &amp; inhibitors</subject><subject>Thrombin - chemistry</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNptkc1uEzEUhS0EKiGwYo3kBeJHyMVjz9gzyzQUiFREUAoLNpbj8RCnM77F9kjNK_JUOEoUumDlxfl87rn3IPS8oOcFZcX77UAp5ZWmtHmAJkXFKClrWj5EE0oZI0ww_hg9iXG7xwrGz9BZXUghqZygP1-s2Wjv4kAudLQtXkQwMA46OI8XfuPWLkGIuIOAL3qAFs9B_xp7nRx4vLIZs3gZINn8O57jy66zJmHocNpYLMlqXMfk0mh9wtlRktngPJCSmE0PAQgnb1yEtHEwButa0P0N3O3eun8pIoZ7SXZY-xbPfHLmkCP7LvN0b3ZP0aNO99E-O75T9P3j5fX8M7n6-mkxn10RzWueSNmx2nLBedVVrLEd5w3TxZqXomnapmkYN1XFa2tFKWVZmXVRcy2p1bQUFROUT9Grg-9tgN-jjUkNLhrb5ywWxqik2INFk8F3B9AEiDHYTt0Gl3faqYKqfXPqXnOZfnG0HdeDbU_ssaqsvzzqOhrdd0F74-IJK6kQNG81ReSAuZjs3UnW4UYJyWWlrpcrtax-_PxQN9_UfuzrA69NVNvcgs-3-2_Av5nhvng</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>Kam, Chih-Min</creator><creator>Kerrigan, John E</creator><creator>Plaskon, R. Richard</creator><creator>Duffy, Edward J</creator><creator>Lollar, Pete</creator><creator>Suddath, F. L</creator><creator>Powers, James C</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940401</creationdate><title>Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency</title><author>Kam, Chih-Min ; Kerrigan, John E ; Plaskon, R. Richard ; Duffy, Edward J ; Lollar, Pete ; Suddath, F. L ; Powers, James C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-4f28e36335f529ef3392a1b34699d99923c5538ee647745cb183a70ea04652603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Anticoagulants - chemistry</topic><topic>Anticoagulants - pharmacology</topic><topic>Binding Sites</topic><topic>Blood Coagulation - drug effects</topic><topic>Cattle</topic><topic>Chemistry</topic><topic>Coumarins - chemistry</topic><topic>Coumarins - metabolism</topic><topic>Coumarins - pharmacology</topic><topic>Exact sciences and technology</topic><topic>Factor IXa - antagonists &amp; inhibitors</topic><topic>Factor VIIIa - pharmacology</topic><topic>Heterocyclic compounds</topic><topic>Heterocyclic compounds with o, s, se, te hetero atom and condensed derivatives</topic><topic>Humans</topic><topic>Hydrolysis</topic><topic>Isocoumarins</topic><topic>Liposomes - metabolism</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Molecular Structure</topic><topic>Organic chemistry</topic><topic>Preparations and properties</topic><topic>Serine Proteinase Inhibitors - chemistry</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Swine</topic><topic>Thrombin - antagonists &amp; inhibitors</topic><topic>Thrombin - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kam, Chih-Min</creatorcontrib><creatorcontrib>Kerrigan, John E</creatorcontrib><creatorcontrib>Plaskon, R. Richard</creatorcontrib><creatorcontrib>Duffy, Edward J</creatorcontrib><creatorcontrib>Lollar, Pete</creatorcontrib><creatorcontrib>Suddath, F. L</creatorcontrib><creatorcontrib>Powers, James C</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kam, Chih-Min</au><au>Kerrigan, John E</au><au>Plaskon, R. Richard</au><au>Duffy, Edward J</au><au>Lollar, Pete</au><au>Suddath, F. L</au><au>Powers, James C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>37</volume><issue>9</issue><spage>1298</spage><epage>1306</epage><pages>1298-1306</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A series of 7-amino-4-chloro-3-(3-isothioureidopropoxy)isocoumarin (NH2-CiTPrOIC) derivatives with various substituents at the 7- and 3-positions have been synthesized as inhibitors of several blood coagulation enzymes. Isocoumarins substituted with basic groups such as guanidino or isothioureidoalkoxy groups were previously shown to be potent irreversible inhibitors of blood coagulation enzymes [Kam et al. Biochemistry 1988, 27, 2547-2557]. Substituted isocoumarins with an isothioureidoethoxy group at the 3-position and a large hydrophobic group at the 7-position are better inhibitors for thrombin, factor VIIa, factor Xa, factor XIa, factor IIa, and factor IXa than NH2-CiTPrOIC (4). PhNHCONH-CiTEtOIC (14), (S)-Ph(CH3)CHNHCONH-CiTEtOIC (25), and (R)-Ph(CH3)CHNHCONH-CiTEtOIC (26) inhibit thrombin quite potently and have kobs/[I] values of (1-4) x 10(4) M-1 s-1. Modeled structures of several isocoumarins noncovalently complexed with human alpha-thrombin suggest that H-bonding between the 7-substituent and the Lys-60F NH3+ relates to the inhibitory potency. Thrombin inhibited by 14, 25, or 26 is quite stable, and only 4-16% of enzymatic activity is regained after incubation for 20 days in 0.1 M Hepes, pH 7.5 buffer. However, 100, 67, and 65% of enzyme activity, respectively, is regained with the addition of 0.38 M hydroxylamine. With normal citrated pig or human plasma, these isocoumarin derivatives prolong the prothrombin time ca. 1.3-3.1-fold and also prolong the activated partial thromboplastin time more than 3-7-fold at 32 microM. Thus, these compounds are effective anticoagulants in vitro and may be useful in vivo.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8176707</pmid><doi>10.1021/jm00035a009</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1994-04, Vol.37 (9), p.1298-1306
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_76465219
source ACS CRKN Legacy Archives
subjects Amino Acid Sequence
Animals
Anticoagulants - chemistry
Anticoagulants - pharmacology
Binding Sites
Blood Coagulation - drug effects
Cattle
Chemistry
Coumarins - chemistry
Coumarins - metabolism
Coumarins - pharmacology
Exact sciences and technology
Factor IXa - antagonists & inhibitors
Factor VIIIa - pharmacology
Heterocyclic compounds
Heterocyclic compounds with o, s, se, te hetero atom and condensed derivatives
Humans
Hydrolysis
Isocoumarins
Liposomes - metabolism
Models, Molecular
Molecular Sequence Data
Molecular Structure
Organic chemistry
Preparations and properties
Serine Proteinase Inhibitors - chemistry
Serine Proteinase Inhibitors - pharmacology
Swine
Thrombin - antagonists & inhibitors
Thrombin - chemistry
title Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A01%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism-Based%20Isocoumarin%20Inhibitors%20for%20Blood%20Coagulation%20Serine%20Proteases.%20Effect%20of%20the%207-Substituent%20in%207-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins%20on%20Inhibitory%20and%20Anticoagulant%20Potency&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Kam,%20Chih-Min&rft.date=1994-04-01&rft.volume=37&rft.issue=9&rft.spage=1298&rft.epage=1306&rft.pages=1298-1306&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00035a009&rft_dat=%3Cproquest_cross%3E76465219%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a383t-4f28e36335f529ef3392a1b34699d99923c5538ee647745cb183a70ea04652603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76465219&rft_id=info:pmid/8176707&rfr_iscdi=true